BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29845204)

  • 1. LncRNA WWOX‑AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells.
    Qu G; Ma Z; Tong W; Yang J
    Mol Med Rep; 2018 Jul; 18(1):779-788. PubMed ID: 29845204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis.
    Dai J; Xu LJ; Han GD; Jiang HT; Sun HL; Zhu GT; Tang XM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S783-S790. PubMed ID: 30260245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
    Wang Z; Tan M; Chen G; Li Z; Lu X
    IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA SERTAD2-3 Inhibits Osteosarcoma Proliferation and Migration by Competitively Binding miR-29c.
    Zhang Z; Liu J; Wu Y; Zhao X; Hao Y; Wang X; Xue C; Wang Y; Zhang R; Zhang X
    Genet Test Mol Biomarkers; 2020 Feb; 24(2):67-72. PubMed ID: 31999493
    [No Abstract]   [Full Text] [Related]  

  • 5. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
    Pan W; Wang H; Jianwei R; Ye Z
    Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of the long non‑coding RNA FOXD2‑AS1 inhibits cell proliferation, migration and invasion in osteosarcoma.
    Zhang H; Lu Y; Wang J; Zhang T; Dong C; Li X; Wang X; Ma Q; Yang T; Zhou Y
    Mol Med Rep; 2019 Jul; 20(1):292-302. PubMed ID: 31115575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA ASBEL promotes osteosarcoma cell proliferation, migration, and invasion by regulating microRNA-21.
    Zhao J; Zhang C; Gao Z; Wu H; Gu R; Jiang R
    J Cell Biochem; 2018 Aug; 119(8):6461-6469. PubMed ID: 29323740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
    Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J
    J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA‑106a regulates the proliferation and invasion of human osteosarcoma cells by targeting VNN2.
    Chen Y; Huang T; Yang X; Liu C; Li P; Wang Z; Zhi S
    Oncol Rep; 2018 Oct; 40(4):2251-2259. PubMed ID: 30066949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA TUSC7 inhibits osteosarcoma progression through the miR‑181a/RASSF6 axis.
    Zhao A; Liu W; Cui X; Wang N; Wang Y; Sun L; Xue H; Wu L; Cui S; Yang Y; Bai R
    Int J Mol Med; 2021 Feb; 47(2):583-594. PubMed ID: 33416181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
    He R; Wu JX; Zhang Y; Che H; Yang L
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA BE503655 inhibits osteosarcoma cell proliferation, invasion/migration via Wnt/β-catenin pathway.
    Huang Q; Shi SY; Ji HB; Xing SX
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31316000
    [No Abstract]   [Full Text] [Related]  

  • 13. Downregulation of lncRNA H19 inhibits migration and invasion of human osteosarcoma through the NF-κB pathway.
    Zhao J; Ma ST
    Mol Med Rep; 2018 May; 17(5):7388-7394. PubMed ID: 29568924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
    Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
    Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.
    Sun XH; Yang LB; Geng XL; Wang R; Zhang ZC
    Int J Clin Exp Pathol; 2015; 8(3):2994-3000. PubMed ID: 26045809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.
    Duan G; Zhang C; Xu C; Xu C; Zhang L; Zhang Y
    Int J Oncol; 2019 Jan; 54(1):17-28. PubMed ID: 30365098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA RBM5-AS1 Promotes Osteosarcoma Cell Proliferation, Migration, and Invasion.
    Deng B; Pan R; Ou X; Wang T; Wang W; Nie Y; Chen H
    Biomed Res Int; 2021; 2021():5271291. PubMed ID: 33816613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lncRNA LET on proliferation and invasion of osteosarcoma cells.
    Kong G; Qi XJ; Wang JF
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1609-1614. PubMed ID: 29630103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA GAS5 Suppresses Cell Growth and Epithelial-Mesenchymal Transition in Osteosarcoma by Regulating the miR-221/ARHI Pathway.
    Ye K; Wang S; Zhang H; Han H; Ma B; Nan W
    J Cell Biochem; 2017 Dec; 118(12):4772-4781. PubMed ID: 28519068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro.
    Wang Y; Yao J; Meng H; Yu Z; Wang Z; Yuan X; Chen H; Wang A
    Mol Med Rep; 2015 Apr; 11(4):2534-40. PubMed ID: 25434862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.